Russell Investments Group
SCLN

Russell Investments Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Russell Investments Group’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-121,942
Closed -$1.37M – 3082
2017
Q3 		$1.37M Sell
121,942
-22,043
-15% -$243K ﹤0.01% 1977
2017
Q2 		$1.58M Sell
143,985
-18,136
-11% -$181K ﹤0.01% 1868
2017
Q1 		$1.59M Buy
162,121
+31,254
+24% +$312K ﹤0.01% 1863
2016
Q4 		$1.4M Buy
+130,867
New +$1.31M ﹤0.01% 2011

Russell Investments Group's SCLN Position: Q4 2017 in Review

Russell Investments Group sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 121,942 shares — an estimated $1.37M sold.

Russell Investments Group first reported a position in SCLN in Q4 2016 and held it in 4 quarters. The position peaked at $1.59M in Q1 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Russell Investments Group reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Russell Investments Group sold 121,942 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $1.37M.
  • Russell Investments Group first reported a position in Sciclone Pharmaceuticals Inc in Q4 2016 and held it in 4 quarters.
  • Russell Investments Group's Sciclone Pharmaceuticals Inc position peaked at $1.59M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Russell Investments Group's 13F filing for Q4 2017, filed 6 Feb 2018.